Detalhe da pesquisa
1.
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?
Med Res Rev
; 44(3): 1055-1120, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142308
2.
IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans.
Infect Immun
; 92(2): e0050423, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193711
3.
The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis.
Clin Infect Dis
; 78(Supplement_2): S175-S182, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662705
4.
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Ann Hematol
; 103(5): 1541-1547, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467825
5.
LaSap vaccine: Immunotherapy and immunochemotherapy associated with allopurinol in dogs naturally infected with Leishmania infantum.
Parasite Immunol
; 46(2): e13028, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389494
6.
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Nature
; 560(7717): 192-197, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30046105
7.
In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
Exp Parasitol
; 257: 108688, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142765
8.
Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL).
Exp Parasitol
; 257: 108687, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114040
9.
A review of non-invasive samples and tools in kala-azar diagnosis and test of cure.
Exp Parasitol
; 259: 108713, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350522
10.
Therapeutic potential of rWnt5A in curbing Leishmania donovani infection.
Infect Immun
; 91(10): e0026723, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725061
11.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
12.
Intramacrophage lipid accumulation compromises T cell responses and is associated with impaired drug therapy against visceral leishmaniasis.
Immunology
; 170(4): 510-526, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635289
13.
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
J Antimicrob Chemother
; 78(11): 2702-2714, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726401
14.
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis.
J Antimicrob Chemother
; 78(7): 1723-1731, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229566
15.
SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection.
Cytokine
; 171: 156373, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776719
16.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774730
17.
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review.
Infection
; 51(2): 507-518, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36329343
18.
Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study.
BMC Infect Dis
; 23(1): 141, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882732
19.
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.
BMC Infect Dis
; 23(1): 885, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110894
20.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Exp Parasitol
; 251: 108555, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247802